The U.S. Department of Justice, on behalf of the EPA have filed a complaint to compel Denka Performance Elastomer to significantly reduce chloroprene emissions from its neoprene manufacturing plant in an area known as ‘Cancer alley’ in LaPlace, Louisiana. The EPA have long held that the company’s operations are a danger to public health due to the cancer risks associated with chloroprene.
According to a preliminary study that is being presented to the American Academy of Neurology’s 75th Annual Meeting this week, exposure to high levels of PM2.5 can be associated with an increased risk of developing Parkinson’s Disease.